National Drug Strategy
National Drug Strategy

Intergovernmental committee on Drugs working party on Fetal Alcohol Spectrum Disorders


Fetal Alcohol Spectrum Disorders in Australia: An Update

June 2012


prev pageTOC |next page

Table of contents

The Intergovernmental Committee on Drugs (IGCD) Working Party on Fetal Alcohol Spectrum Disorders (FASD) thanks the former Ministerial Council on Drugs (MCDS), the IGCD and the Australian Government Department of Health and Ageing (DOHA) for providing the opportunity and funding to produce this monograph. The Editors are grateful for support and assistance provided in reviewing the monograph by a range of organisations and individuals, including all the contributing authors and members of the IGCD Working Party on FASD.

Members of the IGCD Working Party on FASD included: Chair, Mr Keith Evans; Deputy Chair, Prof. Elizabeth Elliott; and Members Dr Lynette Cusack, Ms Jennie Shortt, Ms Kellie Fixter, Dr Matt Edwards, A/Prof Kei Lui, Dr Julee Oei, Dr Andrew White, Dr Kevin Lambkin, Mr Mark West, Prof. David Tudehope, Ms Lynne Biggs, Dr Cindy Clayton, Prof. Agnes Bankier, Prof. Carol Bower, Ms Louise Heuzenroeder, Dr Lucy Burns, Ms Lorian Hayes, Ms Michelle Ricketts and Ms Sarah Venner.

We thank the team within the Drug Strategy Branch from the Australian Government Department of Health and Ageing. We thank Ms Sarah Venner from Drug and Alcohol Services South Australia for secretariat support; A/Professor Jane Halliday of the Murdoch Children’s Research Institute, Dr Priscilla Pyett of the University of Melbourne and Dr Anton Clifford of the National Drug and Alcohol Research Centre for their input; and all delegates of the Fetal Alcohol Spectrum Disorders Workshop held in Adelaide, 19-20 August 2008.

We also thank the Aboriginal Community and Consumer Reference Groups from the Alcohol in Pregnancy Study in Perth and Associate Investigators Dr Julie Owen and Mrs June Councillor. Their assistance with the study into Alcohol and Pregnancy: Aboriginal women’s
knowledge, attitudes and practice, which is included in this report, was invaluable.

The authors acknowledge the support of the National Health and Medical Research Council (NHMRC): Research Fellowships 172303, 353625 and 353628 (Prof Carol Bower), Enabling Grant 402784 and Practitioner Fellowships 457084 and 1021480 (Prof Elizabeth Elliott), Postgraduate Scholarship 457230 (Dr Elizabeth Peadon), Public Health (Australia) Fellowship 594451 (Dr Colleen O’Leary) and Program Grants 353514 and 572742 (2005-09, Prof Carol Bower, Dr Colleen O’Leary, Ms Heather D’Antoine and Dr Jan Payne) and Project Grants 1024474, 1011070 and 630517 (Prof Elizabeth Elliott) and 1024411, 1005668, 630517 (Dr Lucy Burns). The authors would also like to thank the agencies who funded or otherwise supported their research, including (but not limited to) Health Promotion Foundation of WA (Healthway Research Project Grant 10563 and Research Starter Grants 16163 and 17390), Drug and Alcohol Services South Australia (DASSA), the Australian Government Department of Health and Ageing, the University of Sydney (Prof Elizabeth Elliott, Australian Paediatric Surveillance Unit), the National Drug and Alcohol Research Centre (NDARC), University of NSW, the Foundation for Alcohol Research and Education (FARE), Save the Children and Rotary Health.

prev pageTOC |next page